BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$80.4M |
| 2 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$61.6M |
| 3 |
PG&E
PCG
|
+$54.8M |
| 4 |
Deere & Co
DE
|
+$53.1M |
| 5 |
iShares MSCI Japan ETF
EWJ
|
+$28.6M |
Top Sells
| 1 |
Citigroup
C
|
+$1.44B |
| 2 |
Apple
AAPL
|
+$1.03B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$813M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$721M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$651M |
Sector Composition
| 1 | Communication Services | 11.04% |
| 2 | Financials | 10.89% |
| 3 | Healthcare | 10.16% |
| 4 | Technology | 9.96% |
| 5 | Consumer Discretionary | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNA
2851
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $60.6K | ﹤0.01% |
4,964
+2,861
| +136% | +$34.9K |
|
|
MXWL
2852
DELISTED
Maxwell Technologies Inc
MXWL
| $60.3K | ﹤0.01% |
10,461
+7,497
| +253% | +$43.2K |
|
2853
Preformed Line Products
PLPC
$979M
| $60.3K | ﹤0.01% |
848
+602
| +245% | +$42.8K |
|
2854
Utah Medical Products
UTMD
$200M
| $60.2K | ﹤0.01% |
739
+385
| +109% | +$31.3K |
|
|
ASCMA
2855
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $60.2K | ﹤0.01% |
5,235
+2,672
| +104% | +$30.7K |
|
2856
Natera
NTRA
$23.1B
| $59.9K | ﹤0.01% |
6,660
+3,391
| +104% | +$30.5K |
|
2857
Alto Ingredients
ALTO
$91.3M
| $59.9K | ﹤0.01% |
13,156
+8,318
| +172% | +$37.8K |
|
2858
BankFinancial
BFIN
$153M
| $59.9K | ﹤0.01% |
3,902
+3,042
| +354% | +$46.7K |
|
2859
Shore Bancshares
SHBI
$569M
| $59.8K | ﹤0.01% |
3,583
+2,438
| +213% | +$40.7K |
|
|
CALA
2860
DELISTED
Calithera Biosciences, Inc
CALA
| $59.8K | ﹤0.01% |
358
+193
| +117% | +$32.2K |
|
2861
Rockwell Medical
RMTI
$55.8M
| $59.8K | ﹤0.01% |
934
+469
| +101% | +$30K |
|
2862
Tilly's
TLYS
$57.3M
| $59.6K | ﹤0.01% |
4,041
+2,795
| +224% | +$41.3K |
|
2863
Woori Financial
WF
$13.6B
| $59.5K | ﹤0.01% |
+1,332
| New | +$59.5K |
|
|
CRCM
2864
DELISTED
CARE.COM, INC.
CRCM
| $59.5K | ﹤0.01% |
3,296
+2,300
| +231% | +$41.5K |
|
2865
Restaurant Brands International
QSR
$20.6B
| $59.3K | ﹤0.01% |
965
-1,200
| -55% | -$73.8K |
|
|
BLMT
2866
DELISTED
BSB Bancorp, Inc.
BLMT
| $59.3K | ﹤0.01% |
2,026
+1,204
| +146% | +$35.2K |
|
2867
Protagonist Therapeutics
PTGX
$3.66B
| $59.2K | ﹤0.01% |
2,848
+2,190
| +333% | +$45.6K |
|
|
ATRS
2868
DELISTED
Antares Pharma, Inc.
ATRS
| $59.2K | ﹤0.01% |
29,746
+15,277
| +106% | +$30.4K |
|
2869
FreightCar America
RAIL
$162M
| $59.1K | ﹤0.01% |
3,462
+2,181
| +170% | +$37.3K |
|
|
PBNC
2870
DELISTED
PARAGON COMMERCIAL CORPORATION
PBNC
| $59K | ﹤0.01% |
1,109
+688
| +163% | +$36.6K |
|
|
AT
2871
DELISTED
Atlantic Power Corporation
AT
| $58.9K | ﹤0.01% |
25,054
+8,375
| +50% | +$19.7K |
|
|
BHVN
2872
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $58.8K | ﹤0.01% |
2,178
+732
| +51% | +$19.7K |
|
2873
Pacific Biosciences
PACB
$351M
| $58.7K | ﹤0.01% |
22,220
+13,774
| +163% | +$36.4K |
|
|
VSI
2874
DELISTED
Vitamin Shoppe Inc.
VSI
| $58.7K | ﹤0.01% |
13,332
-1,297
| -9% | -$5.71K |
|
|
AKCA
2875
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $58.6K | ﹤0.01% |
3,373
+2,479
| +277% | +$43K |
|